Filing Details

Accession Number:
0001209191-17-002652
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-01-06 16:28:39
Reporting Period:
2017-01-04
Filing Date:
2017-01-06
Accepted Time:
2017-01-06 16:28:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1598646 Minerva Neurosciences Inc. NERV Pharmaceutical Preparations (2834) 260784194
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1617236 S. Mark Levine C/O Minerva Neurosciences, Inc.
1601 Trapelo Road, Suite 284
Waltham MA 02451
Svp,General Counsel & Sec. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-01-04 17,250 $4.71 17,250 No 4 M Direct
Common Stock Acquisiton 2017-01-04 250 $5.19 17,500 No 4 M Direct
Common Stock Disposition 2017-01-04 17,500 $12.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2017-01-04 17,250 $0.00 17,250 $4.71
Common Stock Stock Option (Right to Buy) Disposition 2017-01-04 250 $0.00 250 $5.19
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
51,750 2025-12-03 No 4 M Direct
57,274 2025-04-13 No 4 M Direct
Footnotes
  1. These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 22, 2016.
  2. This option vests as follows: 25% on December 4, 2016 and then in quarterly installments over 3 years thereafter.
  3. This option vests as follows: 25% on April 14, 2016; and then in quarterly installments over 3 years thereafter.